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Enterolobium contortisiliquum trypsin inhibitor (EcTI) belongs to
the Kunitz family of plant inhibitors, which are widely distributed in
nature, especially in plant seeds. EcTI is composed of two
polypeptide chains with a total of 174 residues, homologous to other
inhibitors from the same family. EcTI crystals, which were obtained
with the acupuncture-gel technique, diffract to 2.0 AÊ resolution and
belong to space group P21, with unit-cell parameters a = 37.12,
b = 38.42, c = 54.08 AÊ ,  = 98.08. Molecular-replacement techniques
using Erythrina caffra trypsin inhibitor (PDB code 1tie) as the search
model indicate one monomer in the asymmetric unit. The secondary-
structure content of EcTI was determined by circular dichroism
spectroscopy, yielding values compatible with the expected topology.
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1. Introduction
Protein enzyme inhibitors are distributed in a
wide range of biological materials, but are
especially common in plant seeds and have
been studied in detail because of their appli-
cation as tools in the investigation of enzyme
mechanism and recently in the development of
drugs for the treatment of a variety of
pathologies (Oliva et al., 1999; Patick & Potts,
1998). The serine protease inhibitors are
probably the most intensely investigated
proteins in plant seeds and are divided
according to their structural properties into the
Kunitz, Bowman±Birk, potato, squash and
cereal superfamilies of inhibitors (Richardson,
1991; Oliva et al., 2000).
The Kunitz-type family was originally
named after the puri®cation of the soybean
trypsin inhibitor in the 1940s (Kunitz, 1947a,b);
the structural characteristics of the inhibitor,
its complex formation with trypsin, kinetic
constants etc. have subsequently been well
studied and reviewed (Blow et al., 1974; Sweet
et al., 1974; Kim et al., 1985; Song & Suh, 1998,
De Meester et al., 1998). The Kunitz inhibitors
puri®ed from Leguminosae seeds are proteins
characterized by a molecular weight of around
20 kDa and are composed of approximately
180 amino-acid residues, including four
cysteine residues which form two disul®de
bridges. However, the trypsin inhibitors puri-
®ed from the Mimosoideae subfamily consist
of two polypeptide chains linked by one
disul®de bridge, a peculiarity which is not
shared by the inhibitors from the Caesalpi-
noideae and Papilionoideae subfamilies
(Richardson, 1991).
The overall sequence similarity between all
members of the family strongly suggests that
the origin of the two chains is a post-
translational proteolytic cleavage (Creighton
& Darby, 1989).
E. contortisiliquum is a member of the
Leguminosae, belonging to the Mimosoideae
subfamily, and is a native species found in
South America. It is popularly known as `black
ear', owing to the shape of its fruits (SaÂnchez
de Lorenzo CaÂcere, 1998±2000). Several
proteins have been puri®ed from E. contorti-
siliquum seeds, including enzymes, storage
proteins and protease inhibitors (Oliva et al.,
1988; Sousa & Morhy, 1989; Silva et al., 1994).
Among the inhibitors, a member of the plant
Kunitz inhibitor family, the E. contortisiliquum
trypsin inhibitor (EcTI), has been previously
puri®ed and sequenced (Batista et al., 1996).
The aim of this report is to describe for the ®rst
time preliminary crystallographic and struc-
tural studies of a member of the plant Kunitz
trypsin inhibitors which is composed of
two polypeptide chains, i.e. EcTI. The three-
dimensional structure of this inhibitor is
expected to shed light on its important prop-
erties which include the inhibition of blood
clotting and of ®brinolytic enzymes such as
factor XIIa and plasmin, properties which are
not shared by other members of the same
family of known structure.
2. Experimental
2.1. Purification
The puri®cation of EcTI was performed as
described previously (Batista et al., 1996). The
seed proteins were extracted by swelling 30 g
of the cotyledons with 300 ml 0.15 M NaCl.
After homogenization, the material was
centrifuged at 3000g and the supernatant was
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taken as the starting material (crude
extract), which was initially precipitated
with 80%(v/v) acetone. The resulting preci-
pitate was redissolved in 50 mM Tris±HCl
buffer pH 8.0 and applied to a DEAE-
Sepharose ion-exchange chromatography
column which was equilibrated in the same
buffer and eluted using a linear gradient of
NaCl from 0 to 0.5 M, EcTI being eluted at a
concentration of approximately 0.15 M
NaCl. Protein elution was followed by
measuring the absorbance at 280 nm and the
inhibitory activity was assayed by bovine
trypsin inhibition using benzoyl-argininyl-
p-nitroanilide as substrate. The fractions
showing inhibitory activity were pooled and
applied to a Superdex G75 gel-®ltration
column equilibrated with 0.1 M Tris±HCl
buffer pH 8.0. The protein and inhibitory
activity of the eluted fractions were
measured as described above and the
partially puri®ed EcTI thus obtained was
further chromatographed on a Resource Q
column coupled to an FPLC. In this step, the
column was equilibrated with 50 mM Tris±
HCl buffer pH 8.0 and EcTI was eluted
using a linear gradient of NaCl (0±0.5 M).
The homogeneity of the ®nal preparation
and intermediate stages were checked by
SDS±PAGE (Laemmli, 1970) and isoelectric
focusing using the PhastSystem equipment
from Pharmacia Biotech (Heukeshoven &
Dernick, 1988).
2.2. Circular dichroism
The CD spectra of EcTI were recorded on
a Jasco J-720 spectropolarimeter (wave-
length range 190±300 nm) in quartz cuvettes
of 1 mm path length. The mdegree ellipticity
obtained was transformed into molar ellip-
ticity by the Selcon-1 program using the
mean weight residue and concentration
prior to secondary-structure analysis
(Sreerama & Woody, 1993).
2.3. Crystallization and X-ray data
collection
EcTI was dialyzed against 0.02 M Tris±
HCl buffer pH 8.0 and then concentrated
using a Centricon YM-3 membrane (Milli-
pore) to 7.5 mg mlÿ1. The protein concen-
tration was determined by measuring the
sample absorbance at 280 nm using the
extinction coef®cient of 1.0 for a 1.0 mg mlÿ1
solution of EcTI (Janson & RydeÂn, 1998)
The solution obtained was used to perform
crystallization screens with the Hampton
Research Crystal Screen (Crystal Screen I)
factorial kits employing the hanging-drop
method using multiwell plates at a
temperature of 292 K (McPherson, 1982).
Crystals grew as clusters in the drops
containing factorial solution #50 (Crystal
Screen 1): 15% PEG 8000, 0.5 M lithium
sulfate. This was the only factorial solution
in which promising crystals were obtained.
In order to optimize the initial conditions in
an attempt to obtain single crystals suitable
for X-ray diffraction, a cassette for the
acupuncture-gel technique was prepared
(Moreno & Soriano-Garcia, 1999). Under
these conditions single crystals of EcTI
(Fig. 1) were obtained after three weeks at
292 K using an identical precipitant solution
to that used in the hanging drops.
The X-ray data were collected on a MAR
Research 345 imaging plate at the Protein
Crystallography (PCr) beamline at the
LaboratoÂ rio Nacional de Luz SõÂncrotron
(LNLS), Campinas, Brazil (Polikarpov et al.,
1998). A single crystal was transferred to
mother liquor enriched with 25%(v/v)
glycerol and frozen at 100 K in a nitrogen-
gas stream. The image plate was operated in
the 300 mm scanning mode and the crystal-
to-detector distance was set to 90 mm. Even
though observable diffraction extended to
1.7 AÊ resolution, acceptable data statistics
were only obtained to 1.96 AÊ (Table 1).
2.4. Data processing
All data were processed and scaled using
the programs DENZO and SCALEPACK
(Otwinowski & Minor, 1997). Data reduc-
tion was carried out to 1.96 AÊ resolution.
Owing to poor statistical quality, higher
resolution data were not used. Molecular
replacement using the atomic coordinates of
the Erythrina caffra trypsin inhibitor as a
search model was performed with the
program AMoRe (Navaza & Saludjian,
1997). For this purpose, non-conserved
residues of the Er. caffra structure were
reduced to alanines. Data were used in the
resolution range 10±3 AÊ and the potential
solutions were optimized by rigid-body
re®nement.
3. Results and discussion
The inhibitor from E. contortisiliquum seeds,
EcTI, consists of 174 amino-acid residues
with two disul®de bridges and is homologous
to the Kunitz trypsin inhibitor from Er.
caffra, whose three-dimensional structure
has been previously determined (PDB code
1tie; Onesti et al., 1991). However, the latter
is composed of only a single polypeptide
chain and shares only 39% sequence identity
with EcTI.
The CD spectrum of EcTI was char-
acterized by a minimum at 213 nm. Decon-
volution of the spectrum using the Selcon-1
program yielded estimates of 59% -sheet
and 41% irregular structures. These values
are compatible with those for the single-
chain inhibitor from Er. caffra, which is
composed of 39% -sheet, 57% irregular
structure and 4% 310 helix as assigned using
the program PROMOTIF (Hutchinson &
Thornton, 1996). Several factors may be
responsible for the small discrepancy
between the two sets of values, which
include the relatively large error in deter-
mining secondary-structure content by
deconvolution of CD spectra, the low
overall sequence identity between the two
molecules and the fact that EcTI has
suffered an internal proteolytic cleavage.
EcTI crystals belong to space group P21,
as determined from systematic absences
along b*, with unit-cell parameters a = 37.12,
b = 38.42, c = 54.08 AÊ ,  = 98.08, and diffract
to 1.7 AÊ resolution. The structure determi-
nation via molecular-replacement tech-
niques using the inhibitor from Er. caffra as
a search model indicates the presence of one
monomer in the asymmetric unit. Employing
the known molecular weight of 19 458 Da
(as determined from the amino-acid
sequence), this corresponds to a Matthews
coef®cient of 1.96 AÊ 3 Daÿ1 and a solvent
content of 36.8%, which are both within the
Figure 1
Crystal of EcTI.
Table 1
Data-collection and processing statistics.
Values in parentheses refer to the last shell (2.01±1.96 AÊ ).
Space group P21
Unit-cell parameters (AÊ ,) a = 37.12, b = 38.42,
c = 54.08,  = 98.08
Resolution range (AÊ ) 20±1.96
No. of collected re¯ections 23475
No. of unique re¯ections 11611
Rsym² (%) 10.3 (31.1)
Completeness (%) 87.0 (87.0)
Percentage I/(I) > 2 (%) 80.0 (48.5)
² Rsym =
P
h
P
i jIhi ÿ hIhij/
P
h
P
i Ihi , where I(h) is
the intensity of the re¯ection h,
P
h is the sum over all
re¯ections and
P
i is the sum over all i measurements of the
re¯ection h.
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expected normal ranges. Assuming two
monomers per asymmetric unit leads to an
unrealistic value of 0.98 AÊ 3 Daÿ1 for VM and
a negative solvent content. The best
molecular-replacement solution ( = 63.2,
 = 9.5,  = 141.0, x = 0.3999, y = 0.0000,
z = 0.2396) yielded a correlation coef®cient
of 0.33, 4% above the subsequent potential
solutions which were all clustered around
0.29. The relatively low correlation coef®-
cient observed for the top solution is prob-
ably a consequence of the low overall
sequence identity and the potential (but
unknown) structural consequences of the
internal cleavage of the polypeptide chain in
EcTI.
The similarity between the EcTI and
1tie sequences suggests that their
three-dimensional structures are similar,
consisting of 12 antiparallel -strands joined
by long loops. The scissile bond (Arg63±
Ile64) is expected to be located on an
unconstrained external loop that protrudes
from the surface of the molecule. However,
whilst 1tie is known to inhibit t-PA, plasmin
and trypsin, EcTI also shows high af®nity for
human plasma kallikrein (Ki = 6.15 nM) and
factor XIIa (81.81 nM). The full re®nement
of its structure is expected to contribute to
understanding these differences.
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